|
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
 
|
3/2025
vol. 100 Review paper
Use of probiotics in newborns: a neonatologist’s perspective
Beata Łoniewska
1
,
Igor Łoniewski
2
Pediatr Pol 2025; 100 (3): 243-252
Online publish date: 2025/09/24
Article file
- Use of probiotics.pdf
[0.23 MB]
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
1. Kennedy KM, de Goffau MC, Perez-Muñoz ME, et al. Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. Nature 2023; 613: 639-649. 2.
Bäckhed F, Roswall J, Peng Y, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe 2015; 17: 690-703. 3.
Singh KS, Singh BP, Rokana N, et al. Bio-therapeutics from human milk: prospects and perspectives. J Appl Microbiol 2021; 131: 2669-2687. 4.
Quin C, Estaki M, Vollman DM, et al. Probiotic supplementation and associated infant gut microbiome and health: a cautionary retrospective clinical comparison. Sci Rep 2018; 8: 8283. DOI: https://doi.org/10.1038/s41598-018-26423-3. 5.
Jia Q, Yu X, Chang Y, et al. Dynamic changes of the gut microbiota in preterm infants with different gestational age. Front Microbiol 2022; 13: 923273. DOI: https://doi.org/10.3389/fmicb.2022.923273. 6.
van den Akker CHP, van Goudoever JB, Shamir R, et al. Probiotics and preterm infants: a position paper by the European Society for Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 2020; 70: 664-680. 7.
Kulkarni T, Majarikar S, Deshmukh M, et al. Probiotic sepsis in preterm neonates-a systematic review. Eur J Pediatr 2022; 181: 2249-2262. 8.
Radbone L, Clarke P. Clinical guideline: Routine use of probiotics to prevent necrotising enterocolitis in high risk preterm infants. NHS; 2022. Available at: https://www.eoeneonatalpccsicnetwork.nhs.uk/wp-content/uploads/2022/09/Probiotic-Guideline.pdf. 9.
Roy U, Jessani LG, Rudramurthy SM, et al. Seven cases of Saccharomyces fungaemia related to use of probiotics. Mycoses 2017; 60: 375-380. 10.
Celis Castañeda LA, Morales Camacho WJ, Durán Ochoa NM. Sepsis due to Lactobacillus reuteri in an extreme preterm newborn: case report. Arch Argent Pediatr 2019; 117: e509-e513. DOI: https://doi.org/10.5546/aap.2019.e509 [Article in Spanish]. 11.
Morgan RL, Preidis GA, Kashyap PC, et al.; McMaster Probiotic, Prebiotic, and Synbiotic Work Group. Probiotics reduce mortality and morbidity in preterm, low-birth-weight infants: a systematic review and network meta-analysis of randomized trials. Gastroenterology 2020; 159: 467-480. 12.
Shane AL, Preidis GA. Probiotics in the neonatal intensive care unit – a framework for optimizing product standards. JAMA Pediatr 2023; 177: 879-880. 13.
Merenstein D, Pot B, Leyer G, et al. Emerging issues in probiotic safety: 2023 perspectives. Gut Microbes 2023; 15: 2185034. DOI: https://doi.org/10.1080/19490976.2023.2185034. 14.
Upadhyay RP, Taneja S, Chowdhury R, et al. Effect of prebiotic and probiotic supplementation on neurodevelopment in preterm very low birth weight infants: findings from a meta-analysis. Pediatr Res 2020; 87: 811-822. 15.
Purdel C, Ungurianu A, Adam-Dima I, Margină D. Exploring the potential impact of probiotic use on drug metabolism and efficacy. Biomed Pharmacother Biomedecine Pharmacother 2023; 161: 114468. DOI: https://doi.org/10.1016/j.biopha.2023.114468. 16.
EFSA Panel on Biological Hazards (BIOHAZ); Allende A, Alvarez- Ordóñez A, Bolton D, et al. Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 17: suitability of taxonomic units notified to EFSA until September 2022. EFSA J 2023; 21: e07746. DOI: https://doi.org/10.2903/j.efsa.2023. 7746. 17.
Duffield SD, Clarke P. Current use of probiotics to prevent necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2019; 104: F228. DOI: https://doi.org/10.1136/archdischild-2018-316199. 18.
Agha L, Staiger D, Brown C, et al. Association of hospital adoption of probiotics with outcomes among neonates with very low birth weight. JAMA Health Forum 2023; 4: e230960. DOI: https://doi.org/10.1001/jamahealthforum.2023.0960. 19.
Preidis GA, Berrington JE. Probiotics for preterms: sharing complex decision-making. Nat Rev Gastroenterol Hepatol 2025; 22: 5-6. 20.
Meyer MP, Chow SSW, Alsweiler J, et al. Probiotics for prevention of severe necrotizing enterocolitis: experience of New Zealand neonatal intensive care units. Front Pediatr 2020; 8: 119. DOI: https://doi.org/10.3389/fped.2020.00119. 21.
Mercer EM, Arrieta MC. Probiotics to improve the gut microbiome in premature infants: are we there yet? Gut Microbes 2023; 15: 2201160. DOI: https://doi.org/10.1080/19490976.2023.2201160. 22.
Szajewska H, Berni Canani R, Domellöf M, et al. Probiotics for the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications. J Pediatr Gastroenterol Nutr 2023; 76: 232-247. 23.
Su GL, Ko CW, Bercik P, et al. AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology 2020; 159: 697-705. 24.
Beghetti I, Panizza D, Lenzi J, et al. Probiotics for preventing necrotizing enterocolitis in preterm infants: a network meta-analysis. Nutrients 2021; 13: 192. DOI: https://doi.org/10.3390/nu13010192. 25.
Rolnitsky A, Ng E, Asztalos E, et al. A quality improvement intervention to reduce necrotizing enterocolitis in premature infants with probiotic supplementation. Pediatr Qual Saf 2019; 4: e201. DOI: https://doi.org/10.1097/pq9.0000000000000201. 26.
Tobias J, Olyaei A, Laraway B, et al. Bifidobacterium longum subsp. infantis EVC001 administration is associated with a significant reduction in the incidence of necrotizing enterocolitis in very low birth weight infants. J Pediatr 2022; 244: 64-71.e2. DOI: https://doi.org/10.1016/j.jpeds.2021.12.070. 27.
Sekhon MK, Grubb PH, Newman M, Yoder BA. Implementation of a probiotic protocol to reduce rates of necrotizing enterocolitis. J Perinatol J Calif Perinat Assoc 2019; 39: 1315-1322. 28.
Bui A, Johnson E, Epshteyn M, et al. Utilization of a high potency probiotic product for prevention of necrotizing enterocolitis in preterm infants at a level IV NICU. J Pediatr Pharmacol Ther 2023; 28: 473-475. 29.
Sharif S, Meader N, Oddie SJ, et al. Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants. Cochrane Database Syst Rev 2023; 7: CD005496. DOI: https://doi.org/10.1002/14651858.CD005496.pub6. 30.
Costeloe K, Bowler U, Brocklehurst P, et al. A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial. Health Technol Assess Winch Engl 2016; 20: 1-194. 31.
Samara J, Moossavi S, Alshaikh B, et al. Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants. Cell Host Microbe 2022; 30: 696-711.e5. DOI: https://doi.org/10.1016/ j.chom.2022.04.005. 32.
Sowden M, van Weissenbruch MM, Bulabula ANH, et al. Effect of a multi-strain probiotic on the incidence and severity of necrotizing enterocolitis and feeding intolerances in preterm neonates. Nutrients 2022; 14: 3305. DOI: https://doi.org/10.3390/nu14163305. 33.
Chang CM, Tsai MH, Liao WC, et al. Effects of probiotics on gut microbiomes of extremely preterm infants in the neonatal intensive care unit: a prospective cohort study. Nutrients 2022; 14: 3239. DOI: https://doi.org/10.3390/nu14153239. 34.
Alshaikh B, Samara J, Moossavi S, et al. Multi-strain probiotics for extremely preterm infants: a randomized controlled trial. Pediatr Res 2022; 92: 1663-1670. 35.
Wang Y, Florez ID, Morgan RL, et al. Probiotics, prebiotics, lactoferrin, and combination products for prevention of mortality and morbidity in preterm infants: a systematic review and network meta- analysis. JAMA Pediatr 2023; 177: 1158-1167. 36.
Söderquist Kruth S, Persad E, Rakow A. Probiotic supplements effect on feeding tolerance, growth and neonatal morbidity in extremely preterm infants: a systematic review and meta-analysis. Nutrients 2025; 17: 1228. DOI: https://doi.org/10.3390/nu17071228. 37.
Aceti A, Maggio L, Beghetti I, et al. Probiotics prevent late-onset sepsis in human milk-fed, very low birth weight preterm infants: systematic review and meta-analysis. Nutrients 2017; 9: 904. DOI: https://doi.org/10.3390/nu9080904. 38.
Schneider R, Sant’Anna A. Using probiotics in paediatric populations. Paediatr Child Health 2022; 27: 482-491. 39.
Bell EF, Hintz SR, Hansen NI, et al. Mortality, in-hospital morbidity, care practices, and 2-year outcomes for extremely preterm infants in the US, 2013-2018. JAMA 2022; 327: 248-263. 40.
Denkel LA, Schwab F, Garten L, et al. Protective effect of dual-strain probiotics in preterm infants: a multi-center time series analysis. PLoS One 2016; 11: e0158136. DOI: https://doi.org/10.1371/journal. pone.0158136. 41.
Deshmukh M, Patole S. Prophylactic probiotic supplementation for preterm neonates – a systematic review and meta-analysis of nonrandomized studies. Adv Nutr Bethesda Md 2021; 12: 1411-1423. 42.
Hoang DM, Levy EI, Vandenplas Y. The impact of Caesarean section on the infant gut microbiome. Acta Paediatr Oslo Nor 1992 2021; 110: 60-67. 43.
Jagodzinski A, Zielinska E, Laczmanski L, Hirnle L. The early years of life. Are they influenced by our microbiome? Ginekol Pol 2019; 90: 228-232. 44.
Martín-Peláez S, Cano-Ibáñez N, Pinto-Gallardo M, Amezcua- Prieto C. The impact of probiotics, prebiotics, and synbiotics during pregnancy or lactation on the intestinal microbiota of children born by Cesarean section: a systematic review. Nutrients 2022; 14: 341. DOI: https://doi.org/10.3390/nu14020341. 45.
Carpay NC, Kamphorst K, de Meij TGJ, et al. Microbial effects of prebiotics, probiotics and synbiotics after Caesarean section or exposure to antibiotics in the first week of life: a systematic review. PLoS One 2022; 17: e0277405. DOI: https://doi.org/10.1371/journal. pone.0277405. 46.
Blanco-Rojo R, Maldonado J, Schaubeck M, et al. Beneficial effects of Limosilactobacillus fermentum CECT 5716 administration to infants delivered by Cesarean section. Front Pediatr 2022; 10: 906924. DOI: https://doi.org/10.3389/fped.2022.906924. 47.
Kuitunen M, Kukkonen K, Juntunen-Backman K, et al. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009; 123: 335-341. 48.
Peldan PS, Kukkonen AK, Savilahti E, Kuitunen M. Perinatal probiotic mixture and development of allergic sensitization up to 13 years of age. Int Arch Allergy Immunol 2020; 181: 270-277. 49.
Kopp MV, Muche-Borowski C, Abou-Dakn M, et al. S3 guideline allergy prevention. Allergol Sel 2022; 6: 61-97. 50.
Kamphorst K, Carpay NC, de Meij TGJ, et al. Clinical outcomes following pre-, pro- and synbiotic supplementation after caesarean birth or antibiotic exposure in the first week of life in term born infants: a systematic review of the literature. Front Pediatr 2022; 10: 974608. DOI: https://doi.org/10.3389/fped.2022.974608.
Copyright: © 2025 Polish Society of Paediatrics. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
|
POLSKI
